About Combinostics
Combinostics is a medical imaging AI company specializing in neurological disorders, offering the only complete AI solution for entire patient care pathways of major neurodegenerative diseases. Founded by experts with over 20 years of neuroimaging experience, the company developed the cNeuro platform, which integrates multiple applications to support clinicians from early detection through disease management. The cNeuro platform consists of cMRI for fully automated brain MRI quantification, cDSI for AI-supported differential diagnosis and disease progression prediction, cPET for amyloid and FDG brain PET quantification, and cDAT for automated quantification of DAT SPECT images. The platform combines imaging biomarkers with clinical data, neuropsychological tests, and demographic information to provide comprehensive patient insights. Combinostics serves radiologists, neurologists, and memory clinics across health systems, enabling better collaboration between disciplines. The company's solutions support diagnosis of Alzheimer's disease, frontotemporal dementia, vascular dementia, dementia with Lewy bodies, and multiple sclerosis. With validated imaging biomarkers and machine learning methods trained on data from over 2,000 patients with confirmed neurodegenerative diseases, cNeuro provides quantitative, objective information that helps clinicians make earlier, more confident diagnoses and data-driven decisions about additional testing. The company maintains strong partnerships with leading Nordic institutions and the international clinical community.
Mission & Story
Mission
Patients with neurological disorders need an accurate, early diagnosis for better quality of life for them and their families/caregivers. We aim to continue to innovate new ways to support clinicians in providing the best care for their patients.
Founding Story
Founded by co-founders with extensive neuroimaging backgrounds: Dr. Lennart Thurfjell (20+ years neuroimaging experience from Uppsala University, University of Gothenburg, and GE Healthcare), Dr. Jyrki Lötjönen (25+ years biomedical research at VTT Technical Research Centre of Finland), and Dr. Jussi Mattila (machine learning expertise from VTT Information Technology and Tampere University of Technology).
Clinical Focus
Medical conditions and clinical areas addressed by Combinostics.
Who It Serves
Milestones & Awards
Recent Milestones
Acquisition agreement with SyntheticMR announced November 2024; cDAT application for DAT SPECT quantification released in Europe December 2023; cPET application received FDA 510(k) clearance September 2023; cPET application released in Europe July 2023; Participation in PROMINENT Project for precision medicine in neurodegenerative diseases June 2023
Key Partnerships
Company Details
- Headquarters
- Tampere, Finland
- Employees
- 1-10
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.